Last updated: February 16, 2026
What Is Known About the Drug NDC 29300-0458?
The drug with NDC (National Drug Code) 29300-0458 is identified as Hyaluronic Acid, 1.6% Viscoelastic Solution. It is marketed under the brand Healon by Abbott Medical Optics. This product is used primarily in ophthalmic surgeries, particularly for corneal endothelial protection and intraocular use. It is a single-use sterile solution.
Market Position and Current Usage
Hyaluronic Acid Viscoelastic solutions like Healon are essential in ophthalmic surgeries such as cataract extraction, intraocular lens implantation, and corneal transplants. The market for ophthalmic viscoelastics (OVDs) has experienced steady growth driven by increasing prevalence of cataract and other ocular conditions, coupled with expanding surgical procedures.
Key aspects include:
- Market size: The global ophthalmic viscoelastics market was valued at approximately US$900 million in 2022, expected to reach US$1.2 billion by 2030, with a CAGR of about 4.2% (source: Global Market Insights).
- Market share: The leading brands, including Healon, dominate a significant portion of the market with approximately 40-50% share.
- Competitive landscape: Other major players include Alcon (Healon GV), Bausch + Lomb, and Merck.
Regulatory Status and Market Accessibility
The product has FDA approval for intraocular use in the U.S. and is available via hospital supply channels and ophthalmic surgery centers. Recent regulatory trends focus on ensuring sterility, biocompatibility, and manufacturing standards.
Price Analysis and Projections
Current Pricing Overview
- Average wholesale price (AWP): Approximately US$50 to US$70 per unit in the U.S. (per 5 mL package). Prices fluctuate based on volume discounts, buyer agreements, and regional factors.
- Market pricing: Hospitals and surgical centers often secure discounted procurement prices, averaging US$30-40 per unit.
- Patient-level pricing: Not directly applicable; costs are absorbed by healthcare providers, influenced by insurance reimbursements.
Cost Drivers and Factors Affecting Price
- Manufacturing costs: Premium on sterile filtration, packaging, and quality control.
- Regulatory compliance: Costs linked to FDA and international standards.
- Market competition: Price is often driven downward by generic or substitute products.
- Supply chain factors: Shipping costs, inventory management, and regional distribution influence final pricing.
Future Price Trends (Next 3–5 Years)
- Price stabilization expected: Industry data indicates no significant price hikes anticipated for premium viscoelastics through 2025, barring regulatory changes.
- Potential price decline: With increasing competition and biosimilar or generic entries, prices could decline by 10-20% over the next 3 years in mature markets.
- Premium segment: Some brands could maintain higher prices due to brand loyalty and perceived quality, holding prices within US$50-70 range.
Key Market Influences
- Regulatory approvals for biosimilars or generics: Might drive prices lower.
- Advancements in surgical technology: May influence the amount and type of viscoelastic used, indirectly impacting unit prices.
- Economic pressures and healthcare policies: Reimbursements and cost containment efforts may constrain overall pricing.
Competitive and Market Expansion Projections
- Emergence of biosimilars: Expected by 2025 in some regions, such as Europe and Asia, potentially reducing prices.
- Technological innovation: Development of alternative viscoelastic materials or combined agents could affect demand.
- Geographic expansion: Growth in emerging markets could disrupt current pricing models, often characterized by lower prices due to purchasing power disparities.
Conclusion
The NDC 29300-0458 (Healon) operates within a stable but moderately competitive sector. Prices are currently between US$30-70 per unit in the U.S., with limited potential for significant increases. Industry drivers suggest a trend toward price stabilization or slight decline, influenced mainly by competition and regulatory pressures.
Key Takeaways
- The product is a widely used ophthalmic viscoelastic with stable market demand.
- Current wholesale prices range from US$30-70 per unit in the U.S.
- Industry trends point to price stabilization or decrease over the next 3-5 years.
- Competition from biosimilars and generics is likely to influence future pricing.
- Growing markets in Asia and Latin America could introduce downward pressure but also expand total market size.
FAQs
Q1: What are the main competitors for NDC 29300-0458?
A: Key competitors include Alcon (Healon GV), Bausch + Lomb, and Merck, which offer similar viscoelastic products.
Q2: How has the COVID-19 pandemic affected the market?
A: Disruptions in manufacturing and supply chains temporarily affected availability. However, demand for ophthalmic procedures recovered quickly, maintaining market stability.
Q3: Are biosimilars entering the market for this product?
A: Biosimilar versions are anticipated in Europe and Asia by 2024-2025, with potential for price reductions.
Q4: How does pricing vary regionally?
A: Prices are generally lower outside the U.S., especially in developing markets where procurement margins are tighter.
Q5: What are the key factors driving future demand?
A: Rising prevalence of cataracts, advancements in surgical techniques, and expanding ophthalmic surgeries will sustain demand.
References
- Global Market Insights. "Ophthalmic Viscoelastic Market Size," 2022.
- U.S. Food and Drug Administration. “Approved Ophthalmic Products,” 2023.
- IQVIA. “Pharmaceutical Price and Market Data,” 2023.
- MarketWatch. “Healthcare Trends for Ophthalmic Devices,” 2022.
[1] https://www.globalmarketinsights.com/industry-report/ophthalmic-viscoelastic-market
